Demant ASWILYY 92 EV-to-FCF is 25.20 as of Jul. 03, 2026, which is 32% below its 10-year median of 36.98. GuruFocus rates WILYY with a GF Score™ of 92/100 and a GF Value™ of $23.71 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Demant AS ranks worse than 54.07% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Demant AS's Enterprise Value is $11,771 Mil.
Demant AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $467 Mil. Therefore, Demant AS's EV-to-FCF for today is 25.20.
The historical rank and industry rank for Demant AS's EV-to-FCF or its related term are showing as below:
WILYY'
s EV-to-FCF Range Over the Past 10 Years
Min: 18.12 Med: 36.98 Max: 60.45
Current: 25.2
During the past 13 years, the highest EV-to-FCF of Demant AS was 60.45. The lowest was 18.12. And the median was 36.98.
WILYY's EV-to-FCF is ranked worse than 54.07% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.12
vs WILYY: 25.20
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Demant AS's share price for today is $20.66.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Demant AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.567.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Demant AS EV-to-FCF Related Terms
Demant AS EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Demant AS's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Demant AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Demant AS EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Demant AS's EV-to-FCF falls into.
Demant AS's current Enterprise Value is $11,771 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Demant AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $467 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Demant AS (WILYY) has a EV-to-FCF of 25.20 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Demant AS and its competitors. This is 32% below median its historical median of 36.98. Over the past decade, Demant AS's EV-to-FCF has ranged from 18.12 to 60.45. According to the industry distribution chart, Demant AS ranks #226 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 54.1%.
Is Demant AS's EV-to-FCF too high?
Demant AS's current EV-to-FCF of 25.20 is 32% below median its 10-year median of 36.98. Over the past 10 years, this metric has ranged from a low of 18.12 to a high of 60.45. The Medical Devices & Instruments industry median EV-to-FCF is 23.12. Demant AS's value of 25.20 is 9% above this industry median. Based on the distribution chart, Demant AS ranks #226 out of 418 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Demant AS has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Demant AS's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Demant AS ranks #226 out of 418 companies for EV-to-FCF. This places Demant AS in the lower half of its industry. The industry median EV-to-FCF is 23.12. Demant AS's value of 25.20 is 9% above this benchmark. Historically, Demant AS's own EV-to-FCF has ranged from 18.12 to 60.45 over the past decade. While the company's 10-year median is 36.98 vs. the industry median of 23.12, Demant AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.12, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Demant AS's current EV-to-FCF of 25.20 is 9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Demant AS and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Demant AS's current EV-to-FCF is 25.20, which is 32% below median its own 10-year median of 36.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Based on GuruFocus' analysis, Demant AS (WILYY) is currently considered Modestly Undervalued. The stock's GF Value™ is $23.71, compared to a current price of $20.66 — trading 12.9% below its estimated fair value. The current EV-to-FCF is 25.20, which is 32% below median its 10-year median of 36.98 and 9% above the Medical Devices & Instruments industry median of 23.12. Demant AS's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Demant AS (WILYY), the current EV-to-FCF is 25.20 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Demant AS (WILYY) Overvalued in 2026?
Based on GuruFocus' analysis, Demant AS stock appears to be undervalued.
The current stock price of $20.66 is trading 12.9% below its estimated GF Value™ of $23.71.
GuruFocus considers Demant AS to be Modestly Undervalued.
Key valuation signals for WILYY:
EV-to-FCF: 25.20 (32% below median its 10-year median of 36.98)
GF Value™: $23.71 vs. price of $20.66 (12.9% below fair value)
Industry Position: 9% above the Medical Devices & Instruments median (#226 of 418)
No single metric tells the full story. See the WILYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
92GF Score
Get the complete analysis for WILYY
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WILYY has been successfully added to your 
